Purus Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$324K Sell
1,240
-7
-0.6% -$1.8K 0.09% 133
2026
Q2
$314K Buy
1,247
+45
+4% +$9.7K 0.09% 130
2026
Q1
$261K Buy
1,202
+27
+2% +$5.99K 0.08% 127
2025
Q4
$269K Buy
1,175
+15
+1% +$3.42K 0.08% 121
2025
Q3
$269K Buy
1,160
+8
+0.7% +$1.63K 0.09% 116
2025
Q2
$214K Buy
+1,152
New +$214K 0.07% 132

Other funds holding ABBV

Purus Wealth Management's ABBV Position: Q3 2026 in Review

Purus Wealth Management reduced its AbbVie (ABBV) stake by 0.56% in Q3 2026, selling an estimated $1.8K and leaving 1,240 shares worth $324K. The position accounts for 0.09% of the portfolio, ranked #133.

Purus Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Purus Wealth Management held 1,240 shares of AbbVie worth $324K as of Q3 2026.
  • Purus Wealth Management sold 7 AbbVie shares in Q3 2026, an estimated $1.8K.
  • AbbVie made up 0.09% of Purus Wealth Management's portfolio in Q3 2026, its #133 holding.
  • Purus Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Purus Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.